Skip to main content
Watch Insiders
Market intelligence
PCSAHealthcare

Processa Pharmaceuticals Inc insider activity

In the last 90 days, 5 corporate insiders purchased $100,036 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$100,036
Corporate buyers
5
Latest transaction
Jul 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 1, 2026George K NgChief Executive OfficerOpen Market Purchase3,057$1.93$5,900
Jun 30, 2026Wendy GuyChief Administrative OfficerOpen Market Purchase2,436$1.93$4,701
Jun 30, 2026Patrick LinChief Business - Strategy OffOpen Market Purchase2,106$1.93$4,065
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium